OKYO Pharma (LSE:OKYO) Interest Expense : £-0.08 Mil (TTM As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is OKYO Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. OKYO Pharma's interest expense for the six months ended in Mar. 2023 was £ -0.08 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2023 was £-0.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. OKYO Pharma's Operating Income for the six months ended in Mar. 2023 was £ -6.67 Mil. OKYO Pharma's Interest Expense for the six months ended in Mar. 2023 was £ -0.08 Mil. OKYO Pharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OKYO Pharma Interest Expense Historical Data

The historical data trend for OKYO Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OKYO Pharma Interest Expense Chart

OKYO Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Interest Expense

Get a 7-Day Free Trial

-0.08

OKYO Pharma Semi-Annual Data
	Sep13	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-0.08

OKYO Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.08 Mil.

OKYO Pharma (LSE:OKYO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

OKYO Pharma's Interest Expense for the six months ended in Mar. 2023 was £-0.08 Mil. Its Operating Income for the six months ended in Mar. 2023 was £-6.67 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2023 was £0.00 Mil.

OKYO Pharma's Interest Coverage for the quarter that ended in Mar. 2023 is calculated as

OKYO Pharma did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

OKYO Pharma (LSE:OKYO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OKYO Pharma Ltd (LSE:OKYO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

OKYO:USA OK10:Germany

Address

14/15 Conduit St, Floor 4, London, GBR, W1S 2XJ

Website

https://www.okyopharma.com

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.